Create Alert
Watchlist

Marksans Pharma

₹0.00
0.00 (0.00%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All

Performance

Open
0.00
Prev. Close
0.00
Volume
NA
Total traded value
NA
Upper Circuit
NA
Lower Circuit
NA

Fundamentals

Market Cap₹11,447Cr
ROE15.43%
P/E Ratio(TTM)30.07
EPS(TTM)8.40
P/B Ratio4.64
Dividend Yield0.32%
Industry P/E35.29
Book Value54.44
Debt to Equity0.13
Face Value1
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Marksans Pharma

Marksans Pharma Limited is an India-based pharmaceutical company. The Company is primarily engaged in the business of research, manufacture, marketing and sale of pharmaceutical formulations. The Company produces goods across various therapeutic areas, such as pain management, cough and cold, cardiovascular and central nervous system, anti-diabetic, gastrointestinal, hormonal treatment, and anti-allergic, among others. The Company operates four manufacturing facilities across India, the United Kingdom and the United States. The Company manufactures oral solid tablets, soft gelatin capsules and hard capsules in Goa. It also manufactures non-sterile liquids, ointments and powder products and caters to the United Kingdom, West Africa and the Middle East, which is located in the United Kingdom. The Company has spread its facility to over 7000 square meters and manufactures tablets and capsules in the United States.;
Parent OrganisationMarksans Pharma Limited
Managing DirectorMr. Mark Saldanha
NSE SymbolMARKSANS

Shareholding Pattern

Mar '24
Jun '24
Sep '24
Dec '24
Mar '25
Promoters
43.87%
Retail And Others
29.37%
Foreign Institutions
22.20%
Mutual Funds
3.37%
Other Domestic Institutions
1.18%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Torrent Pharmaceuticals
NA
(0.00%)
58.85
Ajanta Pharma
NA
(0.00%)
35.49
Gland Pharma
NA
(0.00%)
44.52
Eris Lifesciences
NA
(0.00%)
66.22